A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma

Clinical trial NCT03250273 · COMPLETED

Trial details

NCT number: NCT03250273
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Cholangiocarcinoma Cholangiocarcinoma Pancreatic Cancer Metastatic Pancreatic Cancer Unresectable Pancreatic Cancer Unresectable Cholangiocarcinoma

Start date: 2017-11-06
Primary completion: 2020-11-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.